Associate Director for Pediatrics
US Food & Drug Administration
Dr. Gilbert Burckart is presently Associate Director for Pediatrics, Office of Clinical Pharmacology, U.S. Food and Drug Administration. Dr. Burckart has served on the faculties of four universities (Buffalo, Tennessee, Pittsburgh, Southern California) as a Professor of Pharmacy, Pediatrics and Surgery for 33 years prior to coming to the FDA. He has previously served as President of the American College of Clinical Pharmacy and as President of the American College of Clinical Pharmacology. He moved to the US FDA in 2008, and his duties include the direction of the Pediatric Clinical Pharmacology program within the Office of Clinical Pharmacology, and participation in the FDA’s Pediatric Review Committee. His present educational and research program focuses on pediatric drug development studies.
Disclosure information not submitted.
Symposium 3: Assessing the Impact of Obesity During Drug Development: What Can We Do Better?
Sunday, September 8, 2024
1:30 PM – 3:00 PM ET
4 - Regulatory Guidance Impacting the Inclusion of Obese Patients in Clinical Trials
Sunday, September 8, 2024
1:30 PM – 3:00 PM ET